CRO "Precision" Services in Biomarker Development

PROTEOMICS Soluble Markers

Immunoassays to measure circulating and soluble markers
GENOMICS TRANSCRIP- TOMICS

Complete genome and transcriptome analysis with Next-Generation Sequencing and qRT-PCR Profiling
FLOW CYTOMETRY

Preclinical services from target selection and validation up to clinical development for diagnosis, prognosis and monitoring of disease.
ASSAY DEVELOPMENT

Customized assays for specific requirements to implement correct biomarker endpoints
MONOCLONAL ANTIBODIES

Comprehensive services from antigen definition to production and purification of antibodies.
BIOBANKING

A regulatory compliant biobank in the heart of Europe, operated by comptent staff, under strict quality management
BIOMARKER DATA ANALYSES

From exploratory analyses up to predictive models, we offer innovative data analysis services to identify novel biomarkers
Biomarker Regulatory Services

Regulatory qualification of biomarker-based panels in EU and US

Firalis BIOMARKER SERVICES

Firalis provides a comprehensive range of biomarker services from research to clinical trials in key therapeutic areas. Flexible stratification at scientific and technical levels supports biomarker discovery, validation, evaluation and qualification activities. Using our strong expertise and a cutting-edge laboratory equipment, we develop and deliver solutions for biomarker assays customized to your projects.

Our partnerships with the pharma industry have resulted in a high sense of quality and reliability in the data we deliver. Clients are invited to choose from our assay menu and use validation data available ad hoc or from a customized procedure.

Firalis is certified ISO:13485 (GMP compliant) and ISO:9001 for the development & production of CE-marked assays, certified NF S 96-900 for its biobank and accredited* ISO 17025 (GCLP compliant) for testing laboratory.

* Click here to view the methods accredited under accreditation number 8-3139. For full scope visit www.cofrac.fr

Contact us today at sales{at}firalis.com and get additional information on our technical platforms and capabilities

(Conditions Générales de Vente et de Prestations de Services)

Yvan DEVAUX, PhD, Head of Cardiovascular Research Unit at LIH
"The ability of Firalis in reaching large international research grants and collaborating with the best academia, with the reflexes and abilities of a private company, is of great value for successful public-private partnerships. Being from the publicly-funded Luxembourg Institute of Health (LIH), it is a great achievement to work with industrials, and working with Firalis is a rich training and rewarding experience, with collaborative research projects leading to scientific publications and ultimately to valuable research and biomedical tools to push personalized medicine a step forward."
Olivier DANOS, PhD, Sr. VP & CSO at REGENXBIO Inc.
"Initiating and coordinating several collaborative research projects, acquisition of many of the most challenging research funds, from both sides of the Atlantic, all contributed to the acceleration of Firalis, to become one of the European leaders in the field of biomarker discovery and validation in less than 10 years. I am proud to be a founding associate and a member of the scientific advisory board."